Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FURAZOLIDONE Cause Transient ischaemic attack? 19 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Transient ischaemic attack have been filed in association with FURAZOLIDONE. This represents 6.4% of all adverse event reports for FURAZOLIDONE.

19
Reports of Transient ischaemic attack with FURAZOLIDONE
6.4%
of all FURAZOLIDONE reports
19
Deaths
18
Hospitalizations

How Dangerous Is Transient ischaemic attack From FURAZOLIDONE?

Of the 19 reports, 19 (100.0%) resulted in death, 18 (94.7%) required hospitalization, and 18 (94.7%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FURAZOLIDONE. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does FURAZOLIDONE Cause?

Condition aggravated (145) Hyponatraemia (144) Abdominal distension (143) Multiple organ dysfunction syndrome (141) General physical health deterioration (140) Stress (140) Abdominal pain (139) Appendicitis (139) Ascites (139) Sepsis (139)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which FURAZOLIDONE Alternatives Have Lower Transient ischaemic attack Risk?

FURAZOLIDONE vs FUROSEMIDE FURAZOLIDONE vs FUROSEMIDE\SPIRONOLACTONE FURAZOLIDONE vs FUSIDATE FURAZOLIDONE vs FUSIDIC ACID FURAZOLIDONE vs FUTIBATINIB

Related Pages

FURAZOLIDONE Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack FURAZOLIDONE Demographics